Gritstone Bio Inc (GRTS)
0.8367
+0.02
(+2.30%)
USD |
NASDAQ |
May 21, 16:00
0.8367
0.00 (0.00%)
After-Hours: 19:35
Gritstone Bio Cash from Financing (Quarterly): -0.379M for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.379M |
| December 31, 2023 | 15.72M |
| September 30, 2023 | -0.264M |
| June 30, 2023 | 1.017M |
| March 31, 2023 | 8.647M |
| December 31, 2022 | 64.36M |
| September 30, 2022 | 19.34M |
| June 30, 2022 | 0.31M |
| March 31, 2022 | -0.917M |
| December 31, 2021 | 32.88M |
| September 30, 2021 | 56.74M |
| June 30, 2021 | 1.745M |
| March 31, 2021 | 17.40M |
| Date | Value |
|---|---|
| December 31, 2020 | 125.43M |
| September 30, 2020 | 0.037M |
| June 30, 2020 | 4.677M |
| March 31, 2020 | 5.655M |
| December 31, 2019 | 4.267M |
| September 30, 2019 | 0.252M |
| June 30, 2019 | 69.79M |
| March 31, 2019 | 0.086M |
| December 31, 2018 | 90.70M |
| September 30, 2018 | 11.50M |
| June 30, 2018 | 8.228M |
| March 31, 2018 | 0.009M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-0.917M
Minimum
Mar 2022
125.43M
Maximum
Dec 2020
21.34M
Average
5.166M
Median
Cash from Financing (Quarterly) Benchmarks
| Precision BioSciences Inc | 40.10M |
| Humacyte Inc | 62.80M |
| Verastem Inc | 0.846M |
| BioVie Inc | 15.98M |
| Adial Pharmaceuticals Inc | 3.824M |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -33.57M |
| Cash from Investing (Quarterly) | 12.30M |
| Free Cash Flow | -118.27M |
| Free Cash Flow Per Share (Quarterly) | -0.2847 |
| Free Cash Flow to Equity (Quarterly) | -33.90M |
| Free Cash Flow Yield | -121.3% |